• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

13,000 DOW !!!





Got 1000 HGSI this morning at $8.05. Now sitting on $8.26.

No BFD but a fun game to play while on retirement.